Literature DB >> 31990130

TRIM25 and its emerging RNA-binding roles in antiviral defense.

Nila Roy Choudhury1, Gregory Heikel1, Gracjan Michlewski1,2.   

Abstract

The innate immune system is the body's first line of defense against viruses, with pattern recognition receptors (PRRs) recognizing molecules unique to viruses and triggering the expression of interferons and other anti-viral cytokines, leading to the formation of an anti-viral state. The tripartite motif containing 25 (TRIM25) is an E3 ubiquitin ligase thought to be a key component in the activation of signaling by the PRR retinoic acid-inducible gene I protein (RIG-I). TRIM25 has recently been identified as an RNA-binding protein, raising the question of whether its RNA-binding activity is important for its role in innate immunity. Here, we review TRIM25's mechanisms and pathways in noninfected and infected cells. We also introduce models that explain how TRIM25 binding to RNA could modulate its functions and play part in the antiviral response. These findings have opened new lines of investigations into functional and molecular roles of TRIM25 and other E3 ubiquitin ligases in cell biology and control of pathogenic infections. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications RNA Interactions with Proteins and Other Molecules > Protein-RNA Recognition.
© 2020 The Authors. WIREs RNA published by Wiley Periodicals, Inc.

Entities:  

Keywords:  E3 ubiquitin ligase; RNA-binding protein; TRIM25; antiviral defense; innate immunity

Mesh:

Substances:

Year:  2020        PMID: 31990130     DOI: 10.1002/wrna.1588

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  16 in total

1.  Riplet Binds the Zinc Finger Antiviral Protein (ZAP) and Augments ZAP-Mediated Restriction of HIV-1.

Authors:  Marlene V Buckmaster; Stephen P Goff
Journal:  J Virol       Date:  2022-08-01       Impact factor: 6.549

2.  TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is redundant for activating the RIG-I pathway.

Authors:  Nila Roy Choudhury; Ivan Trus; Gregory Heikel; Magdalena Wolczyk; Jacek Szymanski; Agnieszka Bolembach; Rute Maria Dos Santos Pinto; Nikki Smith; Maryia Trubitsyna; Eleanor Gaunt; Paul Digard; Gracjan Michlewski
Journal:  Nucleic Acids Res       Date:  2022-06-23       Impact factor: 19.160

Review 3.  USP15: a review of its implication in immune and inflammatory processes and tumor progression.

Authors:  Anna Georges; Philippe Gros; Nassima Fodil
Journal:  Genes Immun       Date:  2021-04-06       Impact factor: 2.676

4.  An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA.

Authors:  Jianyuan Zhao; Jing Wang; Xu Pang; Zhenlong Liu; Quanjie Li; Dongrong Yi; Yongxin Zhang; Xiaomei Fang; Tao Zhang; Rui Zhou; Tao Zhang; Zhe Guo; Wancang Liu; Xiaoyu Li; Chen Liang; Tao Deng; Fei Guo; Liyan Yu; Shan Cen
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

Review 5.  TRIM Proteins in Host Defense and Viral Pathogenesis.

Authors:  Maria I Giraldo; Adam Hage; Sarah van Tol; Ricardo Rajsbaum
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-08

Review 6.  Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma.

Authors:  Wolfgang Eberhardt; Kristina Haeussler; Usman Nasrullah; Josef Pfeilschifter
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 7.  All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes.

Authors:  Emily Yang; Melody M H Li
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

Review 8.  Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class.

Authors:  Francesca D'Amico; Rishov Mukhopadhyay; Huib Ovaa; Monique P C Mulder
Journal:  Chembiochem       Date:  2021-03-18       Impact factor: 3.164

Review 9.  Roles of long non-coding RNAs and emerging RNA-binding proteins in innate antiviral responses.

Authors:  Yiliang Wang; Yun Wang; Weisheng Luo; Xiaowei Song; Lianzhou Huang; Ji Xiao; Fujun Jin; Zhe Ren; Yifei Wang
Journal:  Theranostics       Date:  2020-07-23       Impact factor: 11.556

10.  ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA.

Authors:  Kristian Lied Wollen; Lars Hagen; Cathrine B Vågbø; Renana Rabe; Tobias S Iveland; Per Arne Aas; Animesh Sharma; Bjørnar Sporsheim; Hilde O Erlandsen; Vuk Palibrk; Magnar Bjørås; Davi M Fonseca; Nima Mosammaparast; Geir Slupphaug
Journal:  J Transl Med       Date:  2021-07-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.